Just returned from the local Meijer and tried to buy 2 boxes of Nexafed. Pharmacist wouldn't let me, said the amount was over the limit and could only buy one. Nexafed was behind the counter and I explained it had abuse deterrent properties but she didn't care, she was indifferent. Told me "only one". Meijer is a huge chain, billion dollar company.
the reincarnation of j.auer. his carcass may lie along side the road but his clumsy, inane blunderbuss spirit lives on.
paul_gathua is a long time loser who has connections to other losers who's goal is to foment nonsense, cast doubt and in general, just make a nuisance of himself/themselves. he and his buddies will infest a mb until he's run off or he gets bored and moves on to another board.
the MF author is a nurse who fancies himself a biotech commentator. he was wrong about ACAD and he will be wrong about CYTK.
if ome makes it to market it's been speculated that it could bring in 10B in revs. remember scientific sessions that are designated "late-breaking" sessions are game changers in the practice of medicine and CYTK got ome into a late-breaking session. that's all big pharma needs to know. look for a buyout in 12 months.
late breaking sessions should not be underestimated. these scientific sessions change the way medicine is practiced. very significant and the message is clear to big pharma.